American Cancer Society National Lung Cancer Roundtable (ACS NLCRT)

In 2024, we set out to make a difference – and we couldn’t be prouder of what we achieved. Our work touched 111 million lives, providing critical support to people facing cancer and their families through essential programs, services, and expert information. None of this would be possible without our dedicated team members, volunteers, and partners. Thank you for standing with us to support cancer patients when they need it most. We’re determined to continue building on that success in the year ahead. Join us: cancer.org/impact2024

VOICES of Black Women is a collective commitment to understanding and improving the health of Black women across the nation.? As we celebrate Women’s History Month, we are calling upon our #ACSNLCRT partners to join us in this movement by sharing VOICES with your organization, membership, or network. Learn more: voices.cancer.org.?

It takes a team of bold, passionate people to change the cancer experience for the better. In 2024, the courageous?support of our partners, donors, and volunteers helped make the American Cancer Society Patient Support Pillar’s?boldest efforts possible. Check out what we accomplished?in 2024 - and take a sneak peek at some of our goals for the upcoming year: cancer.org/impact2024

#ACSVOICES of Black Women is more than a study; it’s a collective commitment to understanding and improving the health of Black women across the nation. Your voice today can change our collective future forever. Get more information at voices.cancer.org.

We’re thrilled to see Dr. Ella A. Kazerooni's exceptional leadership and service to the ACS NLCRT honored by the American Cancer Society! Her impact continues to shape the future of lung cancer care. Read more about her outstanding contributions here: https://bit.ly/4ggytVa

We're thrilled to share that Dr. Ella A. Kazerooni recently won the prestigious Volunteer Leadership Award from the American Cancer Society! As the inaugural Chair of the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT), Dr. Kazerooni has been instrumental in shaping our direction. Stay tuned for more highlights as we celebrate the incredible impact of her leadership and dedication!

The brand new Cancer Facts and Figures 2025 report is here! Access this report: https://lnkd.in/gsGW_9n8 "Lung cancer mortality rates have declined by 61% since 1990 in men and 38% since 2002 in women" Not only is this data an incredible look at how far we've come, but a reminder of how far we still have to go in our mission of creating lung cancer survivors.

Register today?for the next American Cancer Society Webinar for Cancer Coalitions which will discuss "Cancer and Climate Change," on Jan. 14th (2-3 PM EST): https://lnkd.in/gG2mCPCH ? Climate change is increasingly recognized as a threat to both environmental and public health, with potential impacts across the cancer continuum. Learn more here: https://lnkd.in/g6kiSPcz ? During this webinar, you will hear from speakers Leticia Nogueira, PhD, MPH, Scientific Director of Health Services Research at the American Cancer Society; and Gila Neta, PhD, MPP, Program Director with the Implementation Science team in the Office of the Director in the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). ? They will discuss how climate change can increase exposures to cancer risk factors, negatively impact food access and quality, disrupt cancer care treatment, and exacerbate cancer disparities; as well as explore how cancer coalitions can address climate change in their cancer plan updates and implementation efforts. ?? Register today https://lnkd.in/gG2mCPCH

This morning at #NLCRT2024, we covered important topics across the lung cancer continuum, from perspectives on treating locally advanced non-small cell lung cancer to lessons learned from the SCALE Collaboration and state-level lung cancer initiatives. To close out the event, our panel of national experts engages in a special debate over the growing role and future of the use of AI in lung cancer care. We'd like to express our sincere thanks to our sponsors. Your support empowers us to learn, strategize, and collaborate on our shared mission. We'd also like to thank our speakers, attendees, and members for an energizing two days working together to create more #LungCancer survivors! AstraZeneca Merck Johnson & Johnson Regeneron Daiichi Sankyo Bristol Myers Squibb Takeda Oncology Amgen Novocure

We're thrilled to kick off Day 2 of #NLCRT2024 with a keynote presentation by Dr. Pasi J?nne, Senior Vice President for Translational Medicine & Director of the Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute and recipient of the 2024 American Cancer Society Medal of Honor. Dr. J?nne, one of the co-discoverers of EGFR mutations, is joined by an expert panel for this crucial discussion on the lung cancer treatment landscape of the future.